Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Nuwellis (CHFS) Competitors

Nuwellis logo

CHFS vs. QTI, NRXS, VRAYQ, VIVE, ELMD, AVTX, ZNTL, SERA, TARA, and FATE

Should you be buying Nuwellis stock or one of its competitors? The main competitors of Nuwellis include QT Imaging (QTI), NeurAxis (NRXS), ViewRay (VRAYQ), Viveve Medical (VIVE), Electromed (ELMD), Avalo Therapeutics (AVTX), Zentalis Pharmaceuticals (ZNTL), Sera Prognostics (SERA), Protara Therapeutics (TARA), and Fate Therapeutics (FATE). These companies are all part of the "medical" sector.

Nuwellis vs. Its Competitors

Nuwellis (NASDAQ:CHFS) and QT Imaging (NASDAQ:QTI) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, risk, valuation, media sentiment, institutional ownership, earnings and profitability.

65.1% of Nuwellis shares are held by institutional investors. Comparatively, 24.2% of QT Imaging shares are held by institutional investors. 0.6% of Nuwellis shares are held by company insiders. Comparatively, 75.4% of QT Imaging shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Nuwellis has a beta of 1.55, suggesting that its share price is 55% more volatile than the S&P 500. Comparatively, QT Imaging has a beta of -0.2, suggesting that its share price is 120% less volatile than the S&P 500.

QT Imaging has a net margin of 0.00% compared to Nuwellis' net margin of -254.26%. QT Imaging's return on equity of 0.00% beat Nuwellis' return on equity.

Company Net Margins Return on Equity Return on Assets
Nuwellis-254.26% -173.61% -131.01%
QT Imaging N/A N/A -65.94%

In the previous week, Nuwellis had 1 more articles in the media than QT Imaging. MarketBeat recorded 1 mentions for Nuwellis and 0 mentions for QT Imaging. Nuwellis' average media sentiment score of 0.00 equaled QT Imaging'saverage media sentiment score.

Company Overall Sentiment
Nuwellis Neutral
QT Imaging Neutral

QT Imaging has lower revenue, but higher earnings than Nuwellis.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nuwellis$5.51M4.58-$18.11M-$279.28-0.01
QT Imaging$4.00M17.31-$4.03MN/AN/A

Summary

QT Imaging beats Nuwellis on 6 of the 10 factors compared between the two stocks.

Get Nuwellis News Delivered to You Automatically

Sign up to receive the latest news and ratings for CHFS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CHFS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CHFS vs. The Competition

MetricNuwellisElectromedical Equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$25.24M$47.50M$5.85B$10.14B
Dividend YieldN/AN/A5.68%4.60%
P/E Ratio-0.083.9975.4125.98
Price / Sales4.58221.23514.54181.13
Price / CashN/A41.3637.5660.44
Price / Book0.332.4512.156.29
Net Income-$18.11M-$2.66M$3.29B$271.07M

Nuwellis Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CHFS
Nuwellis
N/A$4.18
-0.7%
N/A+272.6%$25.24M$5.51M-0.0866
QTI
QT Imaging
N/A$2.52
+3.3%
N/A+379.4%$68.38M$4.00M0.00N/A
NRXS
NeurAxis
2.2506 of 5 stars
$2.63
+3.5%
$7.00
+166.2%
-21.8%$25.93M$3.22M-1.4319Short Interest ↑
VRAYQ
ViewRay
N/A$0.00
+∞
N/AN/A$18K$102.21M0.00300High Trading Volume
VIVE
Viveve Medical
N/A$0.00
flat
N/AN/A$1K$6.83M0.0070
ELMD
Electromed
3.9629 of 5 stars
$23.95
-3.2%
$36.25
+51.4%
+31.0%$206.48M$64M31.93160News Coverage
Insider Trade
AVTX
Avalo Therapeutics
3.7873 of 5 stars
$9.02
-2.9%
$30.00
+232.6%
+18.5%$122.18M$440K0.0040Short Interest ↓
ZNTL
Zentalis Pharmaceuticals
1.8703 of 5 stars
$1.72
+1.8%
$8.20
+376.7%
-52.7%$121.91M$67.43M-0.76160Positive News
SERA
Sera Prognostics
1.095 of 5 stars
$3.33
+3.1%
N/A-57.5%$121.68M$80K-3.92120News Coverage
TARA
Protara Therapeutics
1.5513 of 5 stars
$3.17
+1.6%
$19.60
+518.3%
+81.5%$120.38MN/A-1.9630Positive News
FATE
Fate Therapeutics
4.0359 of 5 stars
$1.03
-1.0%
$3.30
+220.4%
-74.2%$119.94M$13.63M-0.71550Positive News

Related Companies and Tools


This page (NASDAQ:CHFS) was last updated on 9/13/2025 by MarketBeat.com Staff
From Our Partners